|
2025
|
Invention
|
Pharmacological prophylactics against stress-induced affective disorders in females.
Methods for... |
|
|
Invention
|
Compositions and methods for the treatment of alzheimer's disease and other neurogenerative disea... |
|
2024
|
Invention
|
Isolation of fetal neuronal extracellular vesicles.
A two-step immunoprecipitation technique for... |
|
2023
|
Invention
|
Compositions and methods for the prevention and treatment of stress-induced fear, depressive-like... |
|
|
Invention
|
Method for predicting a subject's response to slc modulator therapy.
The present invention provi... |
|
|
Invention
|
Magnetic resonance spectroscopy frequency and phase correction.
Methods for performing frequency... |
|
|
Invention
|
Neuromelanin-sensitive mri and methods of use thereof.
A neuromelanin sensitive magnetic resonan... |
|
|
Invention
|
Use of neuromelanin-sensitive mri as a biomarker of dopamine function.
The subject matter disclo... |
|
2022
|
Invention
|
System, method and computer-accessible medium for transcranial magnetic stimulation treatment of ... |
|
|
Invention
|
Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders. Bi... |
|
|
Invention
|
Pharmacological prophylactics against stress-induced affective disorders in females. Methods for ... |
|
|
Invention
|
Combination of retromer pharmacological chaperones and exogenous retromer for the treatment of al... |
|
|
Invention
|
Systems, devices, and methods for harmonization of imaging datasets including biomarkers. An exem... |
|
2021
|
Invention
|
Radiolabeled compounds and uses thereof.
Radiolabeled compounds of Formula I are described. Proc... |
|
|
Invention
|
Neuromelanin-sensitive mri and methods of use thereof. A neuromelanin sensitive magnetic resonanc... |
|
|
Invention
|
Compositions and methods against stress-induced affective disorders and their associated symptoms... |
|
|
Invention
|
Prophylactic efficacy of serotonin 4 receptor agonists against stress.
Methods for prophylactica... |
|
|
Invention
|
Use of neuromelanin-sensitive mri as a biomarker of dopamine function. The subject matter disclos... |
|
|
Invention
|
System, method and computer-accessible medium for neuromelanin-sensitive magnetic resonance imagi... |
|
|
Invention
|
Compositions and methods for the prevention of stress-induced fear, depressive-like and anxiety- ... |
|
|
Invention
|
Mitragynine analogs for the treatment of pain, mood disorders and substance use disorders. The pr... |
|
2020
|
Invention
|
Neuromelanin-sensitive mri for assessing parkinson's disease.
A neuromelanin sensitive magnetic ... |
|
|
Invention
|
Neuromelanin-sensitive mri for assessing parkinson's disease. A neuromelanin sensitive magnetic r... |
|
|
Invention
|
Prophylactic efficacy of serotonin 4 receptor agonists against stress. Methods for prophylactical... |
|
|
Invention
|
Method for predicting a subjects response to slc modulator therapy. The present invention provide... |
|
|
Invention
|
Deuterated mitragynine analogs as safer opioid modulators in the mitragynine class.
The present ... |
|
|
Invention
|
Deuterated mitragynine analogs as safer opioid modulators in the mitragynine class. The present i... |
|
2019
|
Invention
|
Treatment of age-related macular degeneration with neurotrophic peptidergic compound.
The treatm... |
|
|
Invention
|
System and method for diagnosis and treatment of neuropsychiatric disorders.
An assay for a GCH1... |
|
2018
|
Invention
|
Use of novel biomarkers in the diagnosis, confirmation, and treatment of parkinson's disease. The... |
|
|
Invention
|
A method for predicting a subject's response to slc modulator therapy. The present invention prov... |
|
|
Invention
|
Engineered t-cell receptors and methods of their use. Novel engineered T-cell receptors including... |
|
|
Invention
|
Use of peptides as biomarkers in the diagnosis, confirmation and treatment of a neurological diso... |
|
|
Invention
|
Peptides as biomarkers in the diagnosis, confirmation and treatment of a neurological disorder an... |
|
|
Invention
|
Method for predicting a subject's response to valproic acid therapy. The present invention provid... |
|
2016
|
Invention
|
System and method for diagnosis and treatment of neuropsychiatric disorders. An assay for a GCH1 ... |
|
|
Invention
|
Neurogenic brain-derived neurotrophic factor peptides. Five tetra peptides corresponding to diffe... |
|
2015
|
Invention
|
Treatment of autism spectrum disorders with ciliary neurotrophic factor peptide mimetic. A method... |
|
|
Invention
|
Treatment of tauopathies by passive immunization targeting the n-terminal projection domain of ta... |
|
|
Invention
|
Treatment of tauopathies with mglur5 antagonists. 307 is induced by the activation of metabotropi... |
|
|
Invention
|
O-glcnacylation treatment for ischemic brain injury.
Cerebral ischemia-reperfusion injury may be... |
